News
OTSKY
34.27
-0.58%
-0.20
J&J hits main goal in early-stage trial for drug delivery system
Seeking Alpha · 18h ago
Citi Sticks to Its Buy Rating for Otsuka Holdings Co (OTSKF)
TipRanks · 3d ago
Weekly Report: what happened at OTSKY last week (0302-0306)?
Weekly Report · 5d ago
J.P. Morgan Remains a Buy on Otsuka Holdings Co (OTSKF)
TipRanks · 5d ago
Weekly Report: what happened at OTSKY last week (0223-0227)?
Weekly Report · 03/02 10:28
Nomura Remains a Hold on Otsuka Holdings Co (OTSKF)
TipRanks · 03/02 10:26
Weekly Report: what happened at OTSKY last week (0216-0220)?
Weekly Report · 02/23 10:28
Neumora Therapeutics Stock Jumps, Analyst Sees Upside In Alzheimer's Treatment
Benzinga · 02/17 19:32
Goldman Sachs Remains a Buy on Otsuka Holdings Co (OTSKF)
TipRanks · 02/16 10:45
Weekly Report: what happened at OTSKY last week (0209-0213)?
Weekly Report · 02/16 10:28
Otsuka Holdings Sees FY2026 GAAP EPS $1.64; Sees Sales $16.360B.
Benzinga · 02/13 22:50
Otsuka Holdings Q4 EPS $0.40 Down From $0.92 YoY, Sales $4.221B Up From $3.938B YoY
Benzinga · 02/13 22:50
Weekly Report: what happened at OTSKY last week (0202-0206)?
Weekly Report · 02/09 10:29
Weekly Report: what happened at OTSKY last week (0126-0130)?
Weekly Report · 02/02 10:29
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
Benzinga · 01/28 10:51
UBS Sticks to Their Hold Rating for Otsuka Holdings Co (OTSKF)
TipRanks · 01/27 10:07
Weekly Report: what happened at OTSKY last week (0119-0123)?
Weekly Report · 01/26 10:29
Positive Report for Otsuka Holdings Co (OTSKF) from Morgan Stanley
TipRanks · 01/23 11:56
Otsuka upgraded to Overweight from Equal Weight at Morgan Stanley
TipRanks · 01/23 11:51
Ionis, Otsuka win EU nod for hereditary angioedema therapy
Seeking Alpha · 01/21 14:17
More
Webull provides a variety of real-time OTSKY stock news. You can receive the latest news about Otsuka Holdings through multiple platforms. This information may help you make smarter investment decisions.
About OTSKY
Otsuka Holdings Co Ltd is a Japan-based company mainly engaged in medical, nutraceutical, consumer and other business activities in Japan and overseas. The Company operates in four business segments. The Medical Business segment produces and sells therapeutic drugs and infusions. The Nutraceutical segment produces and sells functional beverages, quasi-drugs and nutritional supplements. The Consumer Products segment produces and sells mineral water, beverages and food products. The Others segment manufactures paper containers, manufactures synthetic resin molded products, stores products, provides storage space, and produces and sells chemicals and liquid crystal evaluation equipment, spectroscopic analysis equipment, and other products.